1 Functionally intact brain endothelial capillaries were isolated from porcine brain. p-Glycoprotein was localized at the lumenal membrane of intact capillaries by immunohistochemistry using a murine monoclonal antibody and a secondary FITC¯uorescent labelled anti-mouse IgG. Western blot staining of p-glycoprotein in isolated endothelial cells con®rmed the immunohistochemistry. 2 Excretion of the¯uorescent labelled anthelmintic drug Ivermectin (BODIPY-Ivermectin) was studied in the isolated brain endothelial capillaries. Drug accumulation in the capillary lumen was visualized by¯uorescence confocal laser scanning microscopy and was measured by image analysis. Secretion of BODIPY-Ivermectin into the capillary lumen exhibited characteristics of speci®c and energy-dependent transport. Steady state lumenal¯uorescence intensity averaged 1.6 times cellular uorescence and was reduced 3 ± 4 times below cellular levels when metabolism was inhibited by NaCN. 
Introduction
Ivermectin (22,23-dihydroavermectin B 1a , Figure 1 ) is a semisynthetic analogue of avermectin B1, which belongs to a class of macrolide chemicals that act as agonists of gaminobutyric acid receptors in mammals and of glutamategated chloride channels in invertebrates (Bloom, 1996) . Ivermectin is widely used in veterinary and human medicine for the treatment of parasitic infections. Although clinical safety has been proven, there are some contra-indications of the drug, e.g. meningitis, which may be associated with an impaired function of the blood ± brain barrier. Earlier observations of side eects, such as central nervous system dysfunction (Vaughn et al., 1989; Paul et al., 1987) are now assumed to be related to an interaction of Ivermectin with p-In the present study, we used a model of freshly isolated, morphologically and functionally intact porcine brain capillaries and confocal laser scanning microscopy in order to investigate the excretory transport of a¯uorescent Ivermectin derivative (BODIPY-Ivermectin). We further studied the ability of unlabelled Ivermectin to aect the excretion of¯uorescent labelled drugs, which are handled by p-glycoprotein. The data show BODIPY-Ivermectin and Ivermectin being transported across the membrane of brain endothelial cells into the capillary lumen. Thus, for the ®rst time Pgp-interaction of Ivermectin at the blood brain barrier is demonstrated on a cellular level in an intact vascular tissue.
Methods
BODIPY-Ivermectin, BODIPY-Verapamil and FluoresceineMethotrexate were purchased from Molecular Probes (Eugene, OR, U.S.A.). The¯uorescent Cyclosporin-A derivative NBDL-CS was synthesized as described (Schramm et al., 1995) . The p-glycoprotein blocker PSC-833 was obtained from Novartis AG, Basle, Switzerland. All other chemicals were purchased from commercial sources at the highest purity available.
Capillary isolation
Porcine brains were obtained from the local slaughterhouse and capillary vessels were isolated by mechanical disruption of cortical grey matter. Pieces of grey matter were gently homogenized by means of razor blades and a tight ®tting te¯on homogenizer in 3 volumes (v w
71
) of buer A (mM: NaCl 103, KCl 4.7, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, HEPES 15). After addition of the same volume of dextran (®nal concentration 15%), the homogenate was centrifuged at 58006g. The resulting pellet was resuspended in buer B (corresponding to buer A, supplemented with NaHCO 3 (25 mM), glucose (10 mM), Na-pyruvate (1 mM), 0.5% (w v
) bovine serum albumin, BSA) and ®ltered through a 200 mm nylon mesh. The ®ltrate was passed over a glass bead column and washed with 600 ml buer B. The beads were carefully removed from the column and the adhering capillaries were removed by gentle agitation. The capillaries were centrifuged and the resulting pellet was resuspended in ice-cold, BSA-free Krebs-Henseleit-medium. The buers were pregassed with carbogen (95% O 2 /5% CO 2 ) and kept at 48C.
Protein determination and analyses of enzymatic activities
The activities of the capillary marker enzymes alakaline phosphatase (AP; E.C.: 3.1.3.1.) and g-glutamyl-transpeptidase (g-GT, E.C.: 2.3.2.1.) were determined as quality markers of the puri®ed capillaries. AP activity was measured by means of a commercial test kit (Sigma Diagnostics, St. Louis, MO, U.S.A.), the activity of g-GT was determined following a earlier described method (Orlowsky & Meister, 1963) . Protein concentrations were determined by the Bradford-method (Biorad, Munich, Germany).
Fluorescence microscopy
Individual capillaries were transferred to a aluminum foilcovered, te¯on incubation chamber, which contained 0.5 ± 1.0 ml of Krebs-Henseleit-medium with¯uorescent compounds and added transport eectors. All concentrations are listed in the respective ®gure legends. The¯uorescent compounds were dissolved in dimethylsulphoxide (DMSO) and added to the incubation medium. Earlier experiments had demonstrated that the concentrations of DMSO used (41%) had no signi®cant eect on uptake and excretion of the¯uorescent labelled compounds. Analysis by HPTLC of BODIPY-Ivermectin and the other¯uorescent compounds after extraction with ethanol out of the tissue gave no hint for degradation or transformation of the¯uorescent compounds for at least the time of incubation (41 h).
The chamber¯oor was a 262 cm glass cover slip to which the tissue could be easily viewed by means of an inverted confocal laser scanning microscope (Leica, Bensheim, Germany). The 488-nm laser line, and a 530 nm long-pass emission ®lter were employed. The tissue was viewed through a 636water immersion objective. In order to circumvent photobleaching of the¯uorescent compounds a low laser intensity was used (530% of maximum intensity). Under the used conditions of photomultiplier gain settings the tissue auto¯uorescence was not detectable. The images were captured and analysed with the Scion Image software (Beta 3, Scion Corporation, Frederick, MD, U.S.A.). Normally, a ®eld with several capillaries was selected and an epiuorescence image was aquired by averaging 4 ± 8 frames. In earlier studies using¯uoresceine as reference compound, it had been shown, that¯uorescence intensity and¯uoresceine concentration had an approximately linear relationship (Miller & Pritchard, 1991 and Miller, unpublished data) . Here, the data are given as the average of measured pixel intensity rather than the estimated concentration of thē uorescent compounds. The intensities were measured as described for a similar system of renal proximal tubules (Miller, 1995; Schramm et al., 1995) . From each capillary several adjacent cellular and lumenal areas were selected and the average pixel intensity for each area was calculated.
Cell isolation and cell culture
Porcine brain capillary endothelial cells were isolated and cultured as recently described (Gutmann et al., 1999b) . 
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Ivermectin excretion at the blood ± brain barrier S. Nobmann et alPrimary cultures were prepared according to Audus & Borchardt (1986) with the following modi®cations: Cortical grey matter from six freshly obtained porcine brains was minced and incubated in Medium 199, supplemented with Lglutamin (0.8 mM), Penicillin/Streptomycin (100 u ml 71 ; 100 mg ml 71 ), 100 mg ml 71 Gentamycin and HEPES, pH 7.4 (10 mM). Dispase (Roche, Mannheim, Germany) was added to a ®nal concentration of 0.5% and the homogenate was incubated for 2 h at 378C. Cerebral microvessels were obtained after centrifugation at 10006g for 10 min and resupended in medium containing 15% dextran (Sigma, St. Louis, MO, U.S.A.) followed by centrifugation at 58006g for 12 min. The microvessels were subsequently incubated in 20 ml medium containing 1 mg ml 71 collagenase-dispase (Boehringer) for 1.5 to 2 h. The resulting cell suspension was centrifuged for 10 min at 1306g and then, the cell pellet was resupended in 12 ml medium with 10% horse serum. This suspension was added to a discontinous Percoll (Pharmacia, Freiburg, Germany) gradient consisting of Percoll at 1.03 g ml 71 (20 ml) and 1.07 g ml 71 (15 ml). The percoll gradients were centrifuged at 10006g for 10 min. Endothelial cells were enriched at the interface between the two Percoll solutions. Cells were collected and washed twice in medium containing 10% horse serum. The ®nal cell suspension was kept in medium with 20% horse serum and 10% DMSO and stored in liquid nitrogen until use.
For uptake experiments, isolated endothelial cells were seeded with a density of 75,000 cells well 71 onto collagen (Roche, Mannheim, Germany) coated 96-well cell-culture plates. Cells were cultured under standard cell culture conditions using isolation medium without Gentamycin, but 10% horse serum. One day prior to transport experiments the medium was changed to 45% MEM, 45% F12-HAM, 100 mg ml 71 streptomycin, 100 mg ml 71 penicillin G, HEPES (10 mM), Glutamin (2 mM) and Hydrocortison (550 nM).
Western blot experiments P-glycoprotein was detected by Western blot analysis using the monoclonal antibody (Mab) C219, (Alexis, GruÈ nberg, Germany). The Pgp overexpressing cell line (MDR+)P388 was used as positive control for Western blots of Pgp. SDSpolyacrylamide gel electrophoresis was performed with a Mini-Protean II apparatus (Bio-Rad, Munich, Germany). Electrophoresis was carried out at a voltage of 80 V meanwhile the proteins where in the stacking gel and at a constant voltage of 120 V in the separating gel. Proteins were transferred electrophoretically to a nitro cellulose membrane using a Mini Trans-Blot cell (Bio-Rad) for 2.5 h at a constant amperage of 250 mA. The nitrocellulose membranes were incubated with antibody (1 : 20 dilution) in phosphate buered saline containing 0.05% Tween 20, 1% BSA and 1% milk powder for 2 h at 378C. Membranes were washed four times for 15 min and incubated 1 h at room temperature with horseradish peroxidase-conjugated rabbit anti-mouse IgG (1 : 1000; Roche, Mannheim, Germany) in posphate buered saline containing 1% milk powder and 0.05% Tween 20. Then, the membranes were washed and p-glycoprotein was detected using enhanced chemiluminescence reagent (ECL; Amersham, Buckinghamshire, U.K.). Molecular weights were determined using commercially available standards.
Immunohistochemistry
For immunostaining, isolated brain capillaries were transferred onto slides and ®xed for 20 min with 3% paraformaldehyde, 0.1% glutardialdehyde and 3.4% sucrose in PBS. After washing, the capillaries were permeabilized for 15 min with 1% (v v 71 ) Triton X-100 in PBS and again washed. Then, the capillaries were incubated for 1 h at 378C in a humid chamber with the primary antibody (150 ml murine MAB C219, 1 : 20 dilution, Alexis, GruÈ nberg, Germany). After washing the corresponding¯uorochrome conjugated secondary antibody (150 ml FITC-conjugated rabbit antimouse IgG, 1 : 1000 dilution, Roche, Mannheim, Germany) was added for 1 h in a humid chamber in the dark.
Statistics
All pixels are given as mean+s.e.mean. The means were handled as statistically dierent, when the probability value (a) was less than 0.05 by use of an unpaired t-test.
Results

Capillary integrity
Brain endothelial capillaries were isolated from porcine brains by mechanical treatment of cortical grey matter. The capillary fragments were checked for morphological and enzymatic characteristics. Microscopic inspection yielded an average length of 150 ± 350 mm of the capillary fragments. The endothelial marker enzymes alkaline phosphatase and gglutamyltranspeptidase showed an enrichment of activity compared to that of the brain homogenate of 32+1 and 19+4, respectively. Immunhistochemical assessment of pglycoprotein in intact capillaries using a murine monoclonal antibody and a secondary FITC-conjugated rabbit antimouse antibody demonstrated a predominant localization of the protein at the lumenal membrane of the vessels ( Figure  2A ). Only a very faint staining could be seen at the ablumenal membrane of the capillaries. The presence of pglycoprotein was con®rmed by Western-blot analysis of 7-day-old isolated brain capillary endothelial cells kept in monolayer cultures ( Figure 2B ).
When the isolated capillaries were incubated with a marker for paracellular permeation (FITC-Dextran 4000) no¯uores-cence could be detected by confocal microscopy inside the capillary lumens within 60 ± 80 min of incubation, indicating that the integrity of the tight junctions had been maintained during that time period. Thus, the isolated capillaries represent a signi®cant barrier for the diusion of large molecules across the endothelium, which is consistent with in vivo observations.
Transport studies
When porcine brain endothelial capillaries were incubated with micromolar concentrations of BODIPY-Ivermectin, thē uorescence started to accumulate in the cellular compartment within 3 ± 5 min. After 5 ± 10 min high¯uorescence intensities could also be measured inside the capillary lumens. Steady state was reached within 25 ± 30 min. Figure 3 shows a confocal image of a isolated capillary after 30 min incubation with 1 mM BODIPY-Ivermectin. Compared to the¯uores-cence intensity in the medium, which was almost undetectable under the chosen conditions, the intensities inside the cells were signi®cantly higher. The¯uorescence intensity levels inside the lumens at steady state exceeded those in the cells about 1.3 ± 1.6 fold, suggesting uphill transport from bath to lumenal space. Such a pattern of¯uorescence distribution under standard conditions had earlier been observed in a similar system of isolated, functionally intact renal proximal tubules and had been taken as an indication for active secretion from the cellular into the lumenal space (Schramm, 1995; Miller et al., 1997; Gutmann et al., 1999a; .
When the cells were preincubated with 1 mM NaCN for 30 min, the steady state lumenal¯uorescence was signi®-cantly reduced, whereas cellular¯uorescence remained almost unchanged ( Figure 4A ). The ratio of lumenal to cellular uorescence intensity decreased from 1.4+0.2 to 0.24+0.02 in control capillaries and in NaCN-exposed capillaries, respectively. The absolute cellular¯uorescence intensity was comparable in control capillaries and in NaCN exposed tubules. This indicates, that only excretion but not uptake of BODIPY-Ivermectin is dependent on cellular metabolism.
In the presence of increasing concentrations of unlabelled Ivermectin a concentration dependent reduction of the lumenal¯uorescence intensity could be seen, suggesting that transport of BODIPY-Ivermectin was speci®c and shared the same pathway as the unlabelled drug ( Figure 4B ). 
British Journal of Pharmacology vol 132 (3)
Ivermectin excretion at the blood ± brain barrier S. Nobmann et alWhen the capillaries were incubated with substrates and blockers of p-glycoprotein (PSC-833, Cyclosporin A, Verapamil) a signi®cant decrease of lumenal, but not of cellular uorescence could be seen ( Figure 5A ). This ®nding makes it very likely, that BODIPY-Ivermectin is secreted by pglycoprotein across the lumenal membrane of brain capillaries. Conversely, when the transport of BODIPY-Verapamil, a substrate of p-glycoprotein was studied by confocal microscopy in the presence of unlabelled Ivermectin ( Figure  5B ), a reduction of the lumenal¯uorescence was observed, whereas the cellular¯uorescence intensity remained unchanged. To exclude that BODIPY-Ivermectin is excreted by another ABC-transport protein beside p-glycoprotein, we also studied the eect of Leucotriene C 4 , a substrate of proteins belonging to the mrp (multidrug resistance related protein) family, on BODIPY-Ivermectin excretion. LTC 4 had no eect on cellular and lumenal¯uorescence at steady state ( Figure 6A ). In addition, the excretion of Fluoresceinmethotrexate, a¯uorescent substrate of mrp, was not aected by unlabelled Ivermectin or PSC-833, but by LTC 4 ( Figure  6B ).
In isolated brain capillary cells that were kept in monolayer cultures, the uptake of BODIPY-Ivermectin was signi®cantly increased, when the cells were co-incubated with unlabelled Ivermectin or the p-glycoprotein blocker PSC-833 (Figure 7) , supporting the ®nding in the capillaries of a p-glycoprotein interaction of BODIPY-Ivermectin.
Discussion
The results of this study show, that a¯uorescent labelled derivative of Ivermectin, BODIPY-Ivermectin, is transported from the incubation medium to the lumenal space of isolated functionally intact porcine brain capillaries by a process, that is concentrative, energy-dependent and speci®c. Since uptake into the endothelial cells was not aected by NaCN or one of the other compounds added, the pattern of transport is in accordance with the hypothesis of diusional uptake of BI at the brain directed membrane of brain capillaries followed by a carrier-mediated and energy-dependent eux across the lumenal membrane. Earlier observations in mdr1a knock-out mice make it very likely, that the underlying mechanism of that excretion is transport of BODIPY-Ivermectin and unlabelled drug, respectively, by p-glycoprotein: Treatment of mdr1a knock-out mice with Ivermectin exhibited a drastically increased neurotoxicity of the drug in these animals and signi®cantly elevated drug concentrations in the brain of the ABC-transporter de®cient animals compared to the concentration in brains of control animals (Schinkel et al., 1994; 1995) . In a subpopulation of CF-1 mice showing mdr1-de®ciency, concentration in the brain of Ivermectin or cyclosporin A (another p-glycoprotein substrate) was also higher in mdr (7/7) animals compared with mdr (+/+) mice after either i.v. or oral drug administration (Kwei et al., 1999) . These mice, lacking placental p-glycoprotein, also showed an increased susceptibility of teratogenesis induced by an Ivermectin derivative (Lankas et al., 1998) . In the same strain, the no-eect level after a single oral dose was about 100 mg kg
71
, based on neurotoxicity, whereas other experimental animals, which were phylogenetically closer related to humans tolerated large doses of Ivermectin in the mg kg 71 range also after multiple dosing over 2 weeks (Brown, 1998) . In humans, Ivermectin use is precluded in pregnant women, mothers nursing infants under 3 months old, children under 12 years old and people with CNS diseases like meningitis because of potential CNS side eects of the drug.
Our experiments demonstrate that¯uorescent labelled Ivermectin is extruded out of intact brain capillaries by a concentrative eect and that this export process can be suppressed by p-glycoprotein substrates, whereas drug uptake remained unchanged. The excretion of BODIPY-Ivermectin seems to be p-glycoprotein speci®c. Transport was not inhibited by LTC 4 , a very potent inhibitor of proteins belonging to the p-glycoprotein related mrp-family, nor was secretion of Fl-methotrexate, which is mediated by mrp, inhibited by unlabelled Ivermectin. These data are consistent with our earlier observation of an interaction of BODIPYIvermectin and Ivermectin exclusively with p-glycoprotein in isolated functionally intact kidney tubules . They also imply, that attention has to be paid to those drugs that are p-glycoprotein substrates and might exert CNS side eects during coadministration of Ivermectin. Examples of such drugs are HIV-protease inhibitors Gutmann et al., 1999a) , PSC-833 or Cyclosporin A. For the latter, the eect of increased cerebral Ivermectin concentrations accompanied by neurotoxic side eects has been demonstrated in vivo in mice with an otherwise intact blood brain barrier (Marques-Santos et al., 1999) .
The present ®ndings further indicate, that p-glycoprotein is mainly located at the lumenal side of the capillary wall, as indicated by a strong and continous immunostaining. This is dierent from the hypothesis of an astrocyte related localization of Pgp in human tissue as described by others (Golden & Pardridge, 1999; 2000) . Species dierences, diverse antibodies may give an explanation for these dierent ®ndings. The faint and irregular immunostainining at the outer surface of the capillaries does not completely exclude an abluminal localization of Pgp. However, the experimental setup of incubating isolated capillaries excludes the functional assessment of excretion into the incubation medium due to high dilution.
In addition, the study demonstrates, that isolated intact brain capillaries preserve functional activity of p-glycoprotein. Since the functional expression of transport proteins in cultured endothelial cells and cells lines may depend on the chosen culture conditions (El Hafny et al., 1997; Regina et al., 1998) the isolated capillaries represent an excellent in vitro tool to investigate the protective function of that ABCtransporter at the blood ± brain barrier under conditions coming close to the in vivo situation. Ivermectin excretion at the blood ± brain barrier S. Nobmann et al
